Victor A van de Graaf1, Nienke Wolterbeek2, Eduard L A R Mutsaerts3, Vanessa A B Scholtes3, Daniel B F Saris4, Arthur de Gast5, Rudolf W Poolman3. 1. Department of Orthopaedic Surgery, Joint Research, Onze Lieve Vrouwe Gasthuis Amsterdam, Amsterdam, The Netherlands. Electronic address: vandegraaf@gmail.com. 2. Department of Orthopaedic Surgery, St. Antonius Ziekenhuis Nieuwegein, Nieuwegein, The Netherlands. 3. Department of Orthopaedic Surgery, Joint Research, Onze Lieve Vrouwe Gasthuis Amsterdam, Amsterdam, The Netherlands. 4. Department of Orthopaedic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. 5. Department of Orthopaedic Surgery, Clinical Orthopaedic Research Center Midden-Nederland, Diakonessenhuis Utrecht, Utrecht, The Netherlands.
Abstract
PURPOSE: To conduct a meta-analysis of randomized controlled trials comparing the outcome of arthroscopic partial meniscectomy (APM) with conservative treatment in adults with nonobstructive meniscal tears and to recommend a treatment of choice. METHODS: We systematically searched the databases of MEDLINE, Excerpta Medica Database, Cochrane, the National Health Service Centre for Reviews and Dissemination, and Physiotherapy Evidence Database from inception to May 2, 2016. Two authors independently searched the literature and selected eligible studies. The meta-analyses used a random-effects model. The primary outcome was physical function, measured by knee-specific patient-reported outcomes. Secondary outcomes included knee pain, activity level, the progression of osteoarthritis, adverse events, general health, and quality of life. RESULTS: We included 6 randomized controlled trials, with a total of 773 patients, of whom 378 were randomized to APM and 395 were randomized to the control treatment. After pooling the data of 5 studies, we found small significant differences in favor of the APM group for physical function at 2 to 3 months (mean difference [MD] = 3.31; 95% confidence interval [CI] = 0.69-5.93; P = .01; I(2) = 0% [Lysholm knee score]), and at 6 months (MD = 3.56; 95% CI = 0.24-6.88; P = .04; I(2) = 0% (Knee injury and Osteoarthritis Outcome Score [KOOS] and Western Ontario and McMaster Universities Osteoarthritis Index); standardized MD = 0.17; 95% CI = 0.01-0.32; P = .03; I(2) = 0% [Lysholm knee score, KOOS, and Western Ontario and McMaster Universities Osteoarthritis Index]). We also found small significant differences for pain at 6 months (MD = 3.56; 95% CI = 0.18-6.95; P = .04; I(2) = 0% [KOOS] and MD = 0.56; 95% CI = 0.28-0.83; P ≤ .0001; I(2) = 0% [visual analog scale and numeric rating scale]). We found no significant differences after 12 and 24 months. CONCLUSIONS: We found small, although statistically significant, favorable results of APM up to 6 months for physical function and pain. However, we found no differences at longer follow-up. LEVEL OF EVIDENCE: Level I, systematic review and meta-analysis of Level I studies.
PURPOSE: To conduct a meta-analysis of randomized controlled trials comparing the outcome of arthroscopic partial meniscectomy (APM) with conservative treatment in adults with nonobstructive meniscal tears and to recommend a treatment of choice. METHODS: We systematically searched the databases of MEDLINE, Excerpta Medica Database, Cochrane, the National Health Service Centre for Reviews and Dissemination, and Physiotherapy Evidence Database from inception to May 2, 2016. Two authors independently searched the literature and selected eligible studies. The meta-analyses used a random-effects model. The primary outcome was physical function, measured by knee-specific patient-reported outcomes. Secondary outcomes included knee pain, activity level, the progression of osteoarthritis, adverse events, general health, and quality of life. RESULTS: We included 6 randomized controlled trials, with a total of 773 patients, of whom 378 were randomized to APM and 395 were randomized to the control treatment. After pooling the data of 5 studies, we found small significant differences in favor of the APM group for physical function at 2 to 3 months (mean difference [MD] = 3.31; 95% confidence interval [CI] = 0.69-5.93; P = .01; I(2) = 0% [Lysholm knee score]), and at 6 months (MD = 3.56; 95% CI = 0.24-6.88; P = .04; I(2) = 0% (Knee injury and Osteoarthritis Outcome Score [KOOS] and Western Ontario and McMaster Universities Osteoarthritis Index); standardized MD = 0.17; 95% CI = 0.01-0.32; P = .03; I(2) = 0% [Lysholm knee score, KOOS, and Western Ontario and McMaster Universities Osteoarthritis Index]). We also found small significant differences for pain at 6 months (MD = 3.56; 95% CI = 0.18-6.95; P = .04; I(2) = 0% [KOOS] and MD = 0.56; 95% CI = 0.28-0.83; P ≤ .0001; I(2) = 0% [visual analog scale and numeric rating scale]). We found no significant differences after 12 and 24 months. CONCLUSIONS: We found small, although statistically significant, favorable results of APM up to 6 months for physical function and pain. However, we found no differences at longer follow-up. LEVEL OF EVIDENCE: Level I, systematic review and meta-analysis of Level I studies.
Authors: Joshua P Castle; Lafi S Khalil; Muhammad J Abbas; Stephanie DeBolle; Marissa Tandron; Austin G Cross; Guillermo A Rodriguez; Kelechi R Okoroha Journal: J Orthop Date: 2022-04-14
Authors: Denise O'Connor; Renea V Johnston; Romina Brignardello-Petersen; Rudolf W Poolman; Sheila Cyril; Per O Vandvik; Rachelle Buchbinder Journal: Cochrane Database Syst Rev Date: 2022-03-03
Authors: Victor A van de Graaf; Julia C A Noorduyn; Nienke W Willigenburg; Ise K Butter; Arthur de Gast; Ben W Mol; Daniel B F Saris; Jos W R Twisk; Rudolf W Poolman Journal: JAMA Date: 2018-10-02 Impact factor: 56.272
Authors: Jason L Koh; Todd A Zimmerman; Savan Patel; Yupeng Ren; Dali Xu; Li-Qun Zhang Journal: Clin Orthop Relat Res Date: 2018-11 Impact factor: 4.176
Authors: Victor A van de Graaf; Vanessa A B Scholtes; Nienke Wolterbeek; Julia C A Noorduyn; Camille Neeter; Maurits W van Tulder; Daniël B F Saris; Arthur de Gast; Rudolf W Poolman Journal: BMJ Open Date: 2016-12-21 Impact factor: 2.692
Authors: Raine Sihvonen; Mika Paavola; Antti Malmivaara; Ari Itälä; Antti Joukainen; Heikki Nurmi; Juha Kalske; Anna Ikonen; Timo Järvelä; Tero A H Järvinen; Kari Kanto; Janne Karhunen; Jani Knifsund; Heikki Kröger; Tommi Kääriäinen; Janne Lehtinen; Jukka Nyrhinen; Juha Paloneva; Outi Päiväniemi; Marko Raivio; Janne Sahlman; Roope Sarvilinna; Sikri Tukiainen; Ville-Valtteri Välimäki; Ville Äärimaa; Pirjo Toivonen; Teppo L N Järvinen Journal: Ann Rheum Dis Date: 2017-05-18 Impact factor: 19.103